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Background: The natural history of neonatal group B Streptococcus (GBS) is poorly 
understood. Little is known about the bacterial factors influencing the transmission of GBS from 
mother to neonate, or the development of invasive early-onset GBS disease (EOGBS) in 
colonized neonates. We reviewed whether bacterial load and molecular markers are associated 
with GBS vertical transmission and progression to EOGBS.  
Methods: We searched Medline, Embase, Cochrane and Web of Science from inception to 10
th
 
October 2016 for observational studies in English. We also hand-searched reference lists of 
relevant publications and experts cross-checked included studies. Two reviewers independently 
screened studies, extracted data and appraised the quality of included studies using the QUIPS 
tool. We conducted random-effects meta-analyses where possible and narratively synthesized the 
evidence in text and tables.  
Results: Seventeen studies were included from 1,107 records retrieved from electronic databases 
and publication references. Meta-analyses of three studies showed that neonates colonized by 
serotype III had a higher risk of developing EOGBS than serotype Ia (pooled risk ratio [RR] = 
1.51, 95% confidence interval [CI] 1.12 to 2.03) and serotype II (RR = 1.95, 95% CI 1.10 to 
3.45). Eleven studies showed that in heavily colonized mothers 2 to 3 times more neonates were 
colonized, and in heavily colonized neonates up to 15 times more neonates had EOGBS, 
compared to light colonization. Most evidence was pre-2000 and at risk of bias.  
Conclusion: Acknowledging the difficulty of natural history studies, well-controlled studies are 
needed to assess the predictive value of pathogen subtype and heavy load; they may be useful for 
better-targeted prevention. 
Keywords: Streptococcus agalactiae, bacterial load, molecular markers, systematic review, 
transmission 
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Introduction 
Group B Streptococcus (GBS) is the leading cause of morbidity and mortality from neonatal 
sepsis.
1
 Early-onset GBS disease (EOGBS, first six days of life) has a global estimated incidence 
of 0.4 per 1000 live births and a case fatality rate of 12.1%, although this incidence is likely to be 
an underestimate.
2
 A precondition for EOGBS is maternal GBS colonization of the 
gastrointestinal and/or genitourinary tract. A meta-analysis found that GBS colonizes 
approximately 17.9% of women globally, from 11.1% in Southeast Asia to 22.4% in Americas.
3
 
If a woman has GBS vaginal colonization during labor, there is approximately a 36% chance that 
GBS might be transmitted to her neonate.
4
 Without treatment, most neonates colonized with 
GBS will be asymptomatic, but a small proportion (around 1%) will have EOGBS.
5
  
The natural history of GBS disease is poorly understood. There is a paucity of data on the 
pathogen-specific factors influencing the transmission of GBS colonization from mother to 
neonate or the development of invasive EOGBS in colonized neonates. Of 10 GBS 
polysaccharide capsule types, serotype Ia, Ib, II, III and V are more commonly responsible for 
EOGBS.
5-7
 A number of virulence factors, such as clonal complexes and surface proteins have 
also been proposed in laboratory and clinico-epidemiologic studies,
8-10
 and maternal bacterial 
load has been associated with increased neonatal colonization and sepsis.
11
  
Data on the GBS characteristics that increase the risk of neonatal colonization and EOGBS may 
have important implications for targeting intrapartum antibiotic prophylaxis (IAP) prevention to 
only those women at most risk of having a baby with EOGBS. This may reduce exposure to the 
potential harms associated with IAP, such as antimicrobial resistance and Gram negative 
infections as a result of selection pressure and mutations of the organisms causing infection.
12, 13
 
Therefore, we systematically reviewed the evidence on the bacterial load and bacterial molecular 
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markers associated with GBS vertical transmission, and progression from neonatal GBS 
colonization to EOGBS. 
Materials and Methods 
This systematic review is reported according to recommendations from the Preferred Reporting 
Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) 2015 statement.
14
 The 
protocol is registered at the International Prospective Register of Systematic Reviews 
(PROSPERO): CRD42016037196.   
Search strategy and selection criteria  
We conducted electronic searches in MEDLINE, MEDLINE In-Process & Other Non-Indexed 
Citations, EMBASE, Cochrane Library: Cochrane Database of Systematic Reviews, CENTRAL, 
DARE and HTA databases and Science Citation Index Expanded from inception to 10
th
 October 
2016. The search combined both text words and MeSH terms for GBS, neonate/pregnancy and 
bacterial load/molecular markers, and was limited to English and humans (Supplemental Digital 
Content 1, http://links.lww.com/INF/D106). We hand-searched reference lists of included studies 
and relevant systematic reviews and experts cross-checked included studies.  
Two reviewers independently screened titles, abstracts and full texts of all identified records. 
Any disagreements were resolved by discussion, with involvement of a third reviewer if 
necessary. We included cohort or case-control studies that evaluated the association between 
bacterial load or any individual molecular marker with the transition of GBS from (a) maternal 
colonization in the third trimester to neonatal colonization or EOGBS (as defined by authors, 
ideally confirmed by culture from a sterile site; fewer than seven days), (b) maternal colonization 
in labor to neonatal colonization or EOGBS or (c) neonatal colonization to EOGBS. We 
excluded studies in which more than 10% participants were pregnant women before the third 
AC
CE
PT
ED
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
6 
 
trimester [for study objective (a) above] or neonates who had late-onset GBS. However, we 
included any studies where the data for mothers in the third trimester or for neonates less than 
seven days of age could be separated from the other participants regardless of the percentage of 
total participants that met the exclusion criteria. We also excluded studies in which participants 
received an intervention that would interfere with GBS transmission, such as IAP treatment or 
elective caesarean section delivery as well as any studies that were conducted in the context of 
IAP treatments. Finally, we excluded case reports, case series, abstracts, reviews, editorials, 
letters, books, consensus statements and opinions.  
Data extraction and quality assessment  
Two reviewers independently extracted relevant data on an a priori defined and piloted 
extraction sheet. Data included study settings, participants, bacterial factors, outcomes and 
results. Two authors independently appraised the risk of bias of included studies using the 
Quality in Prognosis Studies (QUIPS) tool, judging six risk of bias domains as low, moderate or 
high.
15
 Any disagreements were resolved by discussion, with involvement of a third reviewer if 
necessary. 
Data synthesis 
All analyses were conducted in Stata 14 (Stata Corp, College Station, Texas). Where data 
permitted, we calculated odds ratios (ORs) for case-control studies and risk ratios (RRs) for all 
other designs, along with 95% confidence intervals (CIs). We only conducted meta-analyses on 
the serotypes associated with progression from neonatal GBS colonization to EOGBS because of 
heterogeneity in the studies on the remaining factors. We used a random effects model due to 
anticipated between-study differences.
16
 As only raw numbers and proportions were reported in 
the studies and summary measures such as RRs were not, we calculated the RRs and 95% CIs for 
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each study and pooled them using STATA command metan. Heterogeneity was assessed using 
forest plots, the chi-squared test for heterogeneity with a 10% level of statistical significance and 
the I
2
 statistic where a value of less than 50% represents low to moderate heterogeneity.
17
 
Comparisons were only made for serotypes included in at least two studies. For the remaining 
studies, we conducted narrative syntheses and displayed results in tables and texts.  
Results 
Our search identified 1,107 unique records, of which 17 articles were included in the synthesis 
(see Figure 1 and supplementary material, http://links.lww.com/INF/D106).
7, 18-33
 Study designs, 
bacterial factors, populations and definitions of GBS colonization and EOGBS differed between 
studies (see Table 1). Most studies were cohort, with two case-control studies
21, 31
 and one 
secondary analysis of a control group in a randomized controlled trial.
28
 Nine studies were on 
vertical transmission of GBS colonisation,
18, 20, 23, 25-30
 five on maternal colonization to EOGBS
20, 
26-28, 30
 and eight on neonatal GBS colonization to EOGBS.
7, 19, 21, 22, 24, 31-33
 Thirteen studies were 
conducted before 1990,
19, 20, 22-29, 31-33
 two during the 1990s
21, 30
 and two after 2000
7, 18
 possibly 
as a result of the widespread use of IAP inhibiting natural history studies. Six studies 
investigated the association of serotype,
7, 18, 19, 21, 31, 32
 11 investigated bacterial load
20, 22-30, 33
 and 
one investigated C-protein antigen.
21
 
Risk of bias  
Figure 2 shows the methodological quality of included studies. Risk of bias was considered high 
in two or more QUIPS domains in 10 of 17 studies (59%), and in one domain in 4 of 17 studies 
(24%). No study was judged as low risk of bias in all six domains. The study confounding 
domain had the highest risk of bias, as important potential confounders such as gestational age at 
birth, birth weight, intrapartum fever and prolonged rupture of membranes were not accounted 
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for in 76% of study designs (13/17, high risk).
7, 18, 20-26, 28, 29, 32, 33
 The remaining four accounted 
for some, but not all, relevant confounders (moderate risk).
19, 27, 30, 31
 In the study participation 
domain, nine studies (53%)
18-23, 25, 26, 33
 were at high risk and the remaining eight were at 
moderate risk of selection bias
7, 24, 27-32
 as baseline characteristics were not adequately described 
and/or recruitment methods were not fully stated.  
Serotypes  
Information on serotypes associated with GBS transmission from mother to neonate was 
available from one study. Al-Sweih et al. (2005)
18
 found that mothers colonized with serotypes V 
(13/27, 48%) and Ia (5/11, 45%) on vaginal-anorectal swabs were more likely to transmit GBS 
than mothers colonized with Ib (1/3, 33%), III (11/33, 33%), serotypes not typeable (7/22, 32%), 
and the remaining serotypes.  
Information on serotypes associated with progression from GBS neonatal colonization to 
EOGBS was available in five studies.
7, 19, 21, 31, 32
 Meta-analyses could only be performed on 
three studies,
7, 21, 32
 as the required data were not available in the others. Of the omitted studies, 
Baker et al. (1973)
19
 reported that serotype III was more frequently present in EOGBS cases 
(56%) than in asymptomatic colonization (36%). However, in this study, the number of 
participants in the asymptomatic GBS colonization group was inconsistently reported, therefore, 
the number of participants with each serotype could not be calculated. Similarly, Baker et al. 
(1974)
31
 inconsistently reported the number of individuals with GBS sepsis, so the numbers 
could not be calculated from this study either. 
The pooled RRs from the meta-analyses for EOGBS in neonates colonized by comparisons of 
GBS serotypes are shown in Figure 3. Neonates colonized by serotype III had a higher risk of 
developing EOGBS than neonates colonized by serotype Ia (pooled RR = 1.51, 95% CI 1.12 to 
AC
CE
PT
ED
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
9 
 
2.03, three studies, 439 neonates). Among 261 neonates colonized by serotype III, 98 (37.5%) 
developed EOGBS compared with 45 of 178 (25.3%) colonized by serotype Ia. Similarly, 
neonates colonized by serotype III were twice as likely to have developed EOGBS than neonates 
colonized by serotype II (pooled RR = 1.95, 95% CI 1.10 to 3.45, three studies, 355 neonates). 
Among 261 neonates colonized by serotype III, 98 (37.5%) developed EOGBS compared with 
19 of 94 (20.2%) colonized by serotype II. The forest plots for each comparison are presented in 
Supplementary Figure 1, http://links.lww.com/INF/D106. For the statistically significant 
serotype III comparisons, the forest plots show that the data from Madzivhandila et al. (2011)
7
 
may have had considerable influence on the results.  
Bacterial load 
Eleven studies investigated bacterial load, and although they defined load differently, studies 
agreed that heavy maternal load was more strongly associated with GBS transmission, and heavy 
neonatal load more strongly associated with EOGBS, compared with light load (see Table 2).
20, 
22-30, 33
 Three studies reported the number of colonized sites.
22, 25, 33
 Hoogkamp-Korstanje et al. 
(1982)
25
 found that women colonized in two or more sites compared to one site only were two 
and a half times more likely to have a neonate colonized with GBS (91% versus 36%, RR 
calculated from percentages = 2.53, 95% CI 1.93 to 3.31). Sites swabbed included throat, nose, 
vagina, cervix, rectum and midstream urine in labor. Similarly, two studies found up to a 15 
times higher risk of EOGBS in neonates with three to four colonized sites as compared to one to 
two colonized sites (see Table 2 for results).
22, 33
 Sites reported in these studies were external ear 
canal, umbilicus, oropharynx and rectum within an hour of birth,
22
 and external canal, umbilicus, 
throat and anus within one to two hours of birth.
33
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Three studies reported the number of colony counts on a plate.
23-25
 Hoogkamp-Korstanje et al. 
(1982)
25
 found that heavy maternal colonization (>50 colonies, 87% transmission rate) in labor 
was associated with GBS transmission more often than light (<10 colonies, 30% transmission 
rate) or moderate colonization (10-50 colonies, 50% transmission rate). Gerards et al. (1985)
24
 
combined the number of sites with the number of colony counts, finding that neonates colonized 
in three or more sites with >50 colonies (heavy, 4/8, 50% transmission rate) were more likely to 
have EOGBS than neonates with fewer than three sites with >50 colonies, three or more sites 
with <10 or 10-50 colonies (moderate, 15/35, 42.9% transmission rate) or fewer than three sites 
with <10 or 10-50 colonies (light, 2/44, 4.5% transmission rate). Sites swabbed were nose, 
throat, external auditory meatus, eyes, umbilicus, skin and rectum immediately after admission to 
NICU. Easmon et al. (1985)
23
 also reported the number of colonies in mothers’ vaginas and 
rectum, however, conclusions could not be drawn as data labelling in their report was unclear. 
Three studies investigated colony-forming units (cfu) of GBS finding that the risk of vertical 
GBS transmission and EOGBS increases with cfu of GBS.
26, 29, 30
 Jones et al. (1994)
26
 found a 
statistically significant linear correlation (p<0.001) between the cfu of GBS in mothers’ vaginas 
during delivery and neonates’ rectums at birth, but a poor correlation between cfu of GBS in 
infant umbilical or nasopharyngeal culture with that found in the mother's vagina. They also 
found that mothers’ swabs had to contain at least 102 GBS before their neonate’s swab yielded a 
positive result, and that neonates colonized with ≥105 GBS per rectal swab were delivered by 
mothers colonized with ≥3 x 104 GBS per vaginal swab. Three infants developed EOGBS; two 
had blood culture positive sepsis and one had a positive rectal culture with respiratory distress. 
All three infants had mothers who were heavily colonized with GBS during delivery (7.70x10
6
, 
6.62x10
7
, 2.5x10
6
). However, only two of the infants were heavily colonized (7.02x10
5
, 
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5.25x10
6
); one infant with blood culture positive sepsis was lightly colonized (<10
1
). Authors 
noted that this infant might have been cleaned before culture.
26
 Sensini et al. (1997)
30
 found that 
mothers with ≥106 cfu/GBS ml at the time of delivery were more likely to transmit GBS to their 
neonates than mothers with 10
2 
to 10
6 
cfu/GBS ml (74/148 [50%] versus 34/112 [30%] RR = 
1.65, 95% CI 1.19 to 2.28). One neonate developed EOGBS whose mother had light 
colonization. Persson et al. (1986)
29
 investigated cfu/GBS ml in the mothers’ urine during 
delivery finding that those with ≥104 cfu/GBS ml were six times more likely to transmit GBS to 
their neonates compared to mothers with <10
4 
cfu/GBS ml (6/9 [67%] versus 6/55 [11%] RR = 
6.11, 95% CI 2.52 to 14.81).  
Morales et al. (1986, 1987)
27, 28
 investigated bacterial load in mothers by a rapid slide 
coagglutination test and found that mothers with heavy colonization in labor (GBS antigens 
detectable within five hours) were twice as likely to transmit GBS to their term neonates (24/30 
[80%] versus 35/98 [36%] RR = 2.24, 95% CI 1.63 to 3.09), and three times more likely to 
transmit GBS to their pre-term neonates (8/11 [73%] versus 9/37 [24%] RR = 2.99, 95% CI 1.52 
to 5.87) than mothers with light colonization (agglutination negative at five hours but positive at 
20 hours). They found three cases of term GBS sepsis, all in heavily colonized mothers, and pre-
term GBS sepsis that was four times more likely in heavily compared to lightly colonized 
mothers (7/11 [64%] versus 6/37 [16%] RR = 3.92, 95% CI 1.66 to 9.25). Finally, Boyer et al. 
(1983)
20
 found that neonatal colonization was 3.29 times more likely in heavily colonized 
mothers (intrapartum vaginal culture positive on direct plate as well as selective culture) 
compared to light (intrapartum vaginal culture negative but postpartum rectal or vaginal culture 
positive) or moderate colonization (intrapartum vaginal culture positive on selective culture) 
during labor (69/107 [64%] versus 20/102 [20%] RR = 3.29, 95% CI 2.17 to 4.99). Of the 
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women who transmitted GBS to their infants, heavily colonized women were more likely to have 
neonates colonized at multiple sites (55%) compared to moderate or light colonization (30%, 
p=0.04).
20
 Sites included throat, umbilicus, rectum, external ear and nasogastric aspirate. Four 
neonates developed EOGBS, all in heavily colonized mothers.
20
 
C-protein antigen  
Chun et al. (1991)
21
 examined whether asymptomatic GBS and EOGBS strains reacted to C-
protein antiserum and four antigens – α, β, γ, δ. They found that GBS isolates in 87% (41/47) of 
neonates with EOGBS and 73% (54/74) of asymptomatically colonized individuals reacted to C-
protein antiserum; this difference was not statistically significant. When comparing the 
distribution of the four C protein-associated antigens, antigen δ was expressed more often in 
isolates from neonates with EOGBS (12/41, 29%) than in asymptomatic neonates (10/54, 19%). 
The remaining antigens were present less often in EOGBS (α = 28/41, 68%, β= 7/41, 17%, and 
γ= 15/41, 36.5%) than in healthy neonates (α = 44/54, 81%, β= 15/54, 28%, and γ= 20/54, 37%). 
Summary measures were not calculated as more than one antigen can be expressed in one strain.  
Discussion 
This is the first systematic review investigating bacterial load and molecular markers associated 
with GBS vertical transmission, or progression from neonatal coloniation to EOGBS. Our 
findings suggest that the epidemiology and natural history of neonatal GBS has not been 
extensively researched. Only two bacterial markers have been investigated in addition to 
bacterial load, and most of the evidence is published before 2000 and at high risk of bias. While 
IAP can reduce EOGBS morbidity,
34
 there are potential harms associated with it,
35
 and in current 
prevention approaches some mothers and their neonates may be unnecessarily treated and 
exposed to these potential harms. For example, in a screening program, up to 30% of GBS 
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positive pregnant women may become negative by birth,
24
 and only 1% of GBS positive women 
in labor will have a baby with EOGBS;
5
 all of these women and their neonates would be 
unnecessarily treated and potentially exposed to the harms. Similarly, approximately 5% of GBS 
negative pregnant women may become positive by birth and would not be treated. Bacterial 
factors could provide innovative opportunities for more efficient prevention, allowing patients 
with the hypervirulent strains of GBS to be targeted, avoiding unnecessary exposure to IAP and 
reducing potential under-treatment. Bacterial load is the most promising of the factors, as 
irrespective of how it was defined and measured, heavier load was consistently associated with 
GBS transmission and EOGBS. Women colonized with heavy GBS load had approximately two 
to three times higher risk of having a neonate colonized with GBS compared to mothers with 
light load. Heavier GBS load in neonates was also consistently associated with EOGBS. The 
pooled comparison of serotypes in GBS colonized neonates showed that the risk of EOGBS 
disease was highest for neonates colonized with serotype III.  
Previous literature shows that serotype III, along with Ia, Ib, II and V, is one of the most 
frequently identified invasive neonatal serotypes.
2, 5-7
 Our review showed that compared to Ia 
and II, serotype III is more often associated with invasive EOGBS. Contrary to expectations, we 
found no evidence of a difference between non-typeable and other serotypes. When comparing 
colonized mothers to EOGBS cases, Fabrini et al. (2016), for example, found no cases of 
EOGBS in neonates with a non-typeable serotype compared with 8% of colonized mothers who 
had a non-typeable serotype.
36
 We may not have found this difference in our review as there 
were only 23 neonates colonized with a non-typeable serotype in the meta-analysis. Within 
serotype III, a study excluded from this review due to the context of IAP found that ST-17 was 
the most common sequence type amongst invasive serotype III strains.
37
 Laboratory experiments 
AC
CE
PT
ED
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
14 
 
have demonstrated that a determinant of this hypervirulence is a ST-17 specific surface protein, 
which promotes attachment to intestinal and meningeal cells.
38
 ST-17 is also more likely to 
invade decidual cells than colonizing strains.
39
  
The finding that heavy bacterial load is consistently associated with GBS vertical transmission 
and EOGBS is in line with evidence that women with GBS bacteriuria (a surrogate for heavy 
maternal colonization) have a higher risk of delivering neonates who develop EOGBS.
40, 41
 There 
is also more recent evidence (excluded as the study was conducted in the context of IAP) 
showing that heavy neonatal colonization as defined by the number of sites is more strongly 
associated with EOGBS than light load (25/1000 versus 4/1000 respectively, p<0.001).
42
 In 
contrast, evidence on the association directly between maternal load and EOGBS was slightly 
unclear, possibly due to the small numbers of EOGBS in such studies. We were only able to 
perform analyses on one study, where pre-term EOGBS was almost four times more likely in 
infants with heavily colonized mothers.
27
  
Several limitations of the evidence should be considered. The risk of bias across the evidence 
was high or moderate, especially regarding confounding variables and study participation 
domains. Furthermore, we calculated the point and interval estimates (RRs, ORs and 95% CIs) 
reported in this review using unadjusted statistical analyses which did not control for potential 
confounders. Therefore, the identified relationships could be partially or entirely due to 
confounding factors. Majority of the evidence is also published before 2000 and may not be 
applicable to today’s context. For example, the association of serotypes with invasive disease 
may be influenced by circulating strains or clones rather than serotype alone, and these 
associations may change over time. To fully understand the mechanisms of virulent GBS types, 
and to confirm that bacterial load is independently associated with EOGBS, larger and better-
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controlled studies are required. We acknowledge that such a study may no longer be feasible as 
IAP is now the recommended treatment. However, it may be possible to conduct a prospective 
cohort study in contexts where IAP prevention is not adopted, for example, in countries in Africa 
or Asia. Alternatively, it might be possible to conduct a retrospective cohort study on culture 
positive mothers who did not end up being treated in screening programs across countries. 
Clinical studies are required to confirm findings on other virulence factors indicated from 
laboratory studies,
8, 9
 as they are not yet available. 
There are also some limitations of our review. Studies in which participants were given IAP were 
excluded, as IAP would interfere with the natural history of GBS transmission and progression to 
EOGBS. This may have resulted in the exclusion of more recent studies, as it may be less 
feasible to conduct studies on untreated women only. As such, it may be worth systematically 
reviewing whether serotype, bacterial load and other factors predict risk of transmission and 
EOGBS in the presence of IAP. As non-English studies were also excluded, prognostic studies in 
other languages may have been missed.  
Conclusions 
While IAP treatment can reduce EOGBS morbidity,
34
 the persistence of EOGBS combined with 
the potential harms from IAP stress the need for better targeted prevention and therapy. Bacterial 
load, serotype, sequence type and the more specific isolate characterization feasible with the 
advent of genome sequencing, could potentially be involved in guiding future prevention 
interventions. There is good evidence to further investigate serotype, and particularly bacterial 
load, in better quality studies. Beyond these factors, greater insights into the mechanisms which 
underlie the natural history of GBS vertical transmission and EOGBS are essential for the 
development of new interventions to prevent EOGBS. 
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Figure legends 
Figure 1: Flow diagram of study selection  
See supplementary information for list of excluded studies with reasons 
Figure 2: Risk of bias across included studies, according to the QUIPS tool
15
 
Figure 3. Pooled relative risk of EOGBS by colonising GBS serotypes in neonates 
Comparisons should be read from right to left. The pooled estimate is located at the intersection 
of the row-defining serotype and column-defining serotype. A RR value greater than 1 means 
higher risk of early-onset group B Streptococcus disease (EOGBS) in neonates colonised by the 
row-defining serotype. For example, neonates colonised by serotype III had a higher risk of 
developing EOGBS than neonates colonised by serotype Ia (pooled RR = 1.51, 95% CI 1.12 to 
2.03). RRs for comparisons in the opposing direction can be established by using reciprocals. 
Significant results are in bold and underlined.  
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Table 1: Characteristics of included studies 
Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
Al-Sweih 
200518 
Kuwait 
Prospective 
cohort 
study  
Serotype Maternal 
colonisation 
to neonatal 
colonisation 
124 women 
colonised with 
GBS on vaginal-
anorectal swabs 
in labour 
(selective 
culture) 
74 neonates 
colonised with 
GBS on external 
ear canal and 
umbilicus swabs 
at unspecified 
time (selective 
culture) 
Baker  
197319 
USA 
Prospective 
cohort 
study  
Serotype Neonatal 
colonisation 
to EOGBS 
disease 
66 neonates 
colonised with 
GBS on throat 
and umbilical or 
external auditory 
canal swabs at 
mean age of 13.8 
hours (selective 
culture) 
12/13 neonates 
with 
bacteriologically 
confirmed 
EOGBS disease 
≤10 days (all 
infants developed 
symptoms in the 
first five days of 
life) 
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
Baker  
197431 
USA 
Case-
control 
study 
Serotype Neonatal 
colonisation 
to EOGBS 
disease 
53 neonates 
colonised with 
GBS on throat, 
umbilical cord or 
ear swabs at <3 
days 
Unknown number 
of neonates with 
EOGBS sepsis or 
pneumonia: 
clinical symptoms 
and pre-mortem 
blood cultures or 
post-mortem heart 
and lung cultures 
in neonates with 
pneumonia 
15 neonates with 
EOGBS 
meningitis: CSF 
culture ≤5 days  
 
Chun  
199121 
USA 
Case-
control 
study 
Serotype, 
Reaction 
to c-
protein 
Neonatal 
colonisation 
to EOGBS 
disease 
121 neonates 
colonised with 
GBS at birth on 
nasopharynx, 
47 neonates with 
EOGBS sepsis: 
Blood and CSF 
culture <7 days 
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
and c-
protein ß 
antigen 
gene 
throat, umbilicus 
or rectum swabs 
Embil  
198732 
Canada 
Prospective 
cohort 
study   
Serotype Neonatal 
colonisation 
to EOGBS 
disease 
55 strains from 
54 neonates 
colonised with 
GBS on rectal 
swabs within 1 
hour of birth 
(selective 
culture) 
12 neonates with 
symptomatic 
EOGBS <3 days  
 
Madzivhandila 
2011
7
  
South Africa 
Prospective 
cohort 
study 
Serotype Neonatal 
colonisation 
to EOGBS 
disease 
525 neonatal 
isolates 
colonised with 
GBS on ears, 
nose and 
umbilicus swabs 
shortly after birth 
(standard 
136 neonates with 
EOGBS: Blood 
and CSF culture 
<7 days AC
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
culture) 
Hoogkamp 
1982
25
 
Netherlands 
Prospective 
cohort 
study  
Bacterial 
load - 
number of 
positive 
sites,  
number of 
colony 
counts per 
plate 
Maternal 
colonisation 
to neonatal 
colonisation 
46 women 
colonised with 
GBS on throat, 
nose, vagina, 
cervix, rectum 
and midstream 
urine swabs in 
labour (selective 
culture) 
Unknown number 
of neonates 
colonised with 
GBS on skin, 
throat, external 
ears and umbilicus 
swabs at <6 hours 
of birth (selective 
swab)  
Dillon  
198722 
USA 
Prospective 
cohort 
study 
Bacterial 
load - 
number of 
positive 
sites 
Neonatal 
colonisation 
to EOGBS 
1448 neonates 
colonised with 
GBS on external 
ear canal, 
umbilicus, 
oropharynx and 
rectum swabs 
within 1 hour of 
birth (selective 
culture) 
24 neonates with 
EOGBS: 
Symptoms and 
blood, CSF, urine 
and other clinical 
specimens <3 
days AC
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
Pass  
197933 
USA 
Prospective 
cohort 
study 
Bacterial 
load - 
number of 
positive 
sites 
Neonatal 
colonisation 
to EOGBS 
290 neonates 
colonised with 
GBS on external 
canal, umbilicus, 
throat and anus 
swabs 1-2 hours 
after birth 
(selective 
culture) 
8 neonates with 
EOGBS: Blood 
and CSF culture 
Easmon 
198523 
England 
Prospective 
cohort 
study 
Bacterial 
load - 
number of 
colony 
counts per 
plate 
Maternal 
colonisation 
to neonatal 
colonisation 
140 women 
colonised with 
GBS on vaginal 
swabs in labour 
(selective and 
standard culture) 
38 neonates 
colonised with 
GBS on rectum, 
umbilicus, ear and 
external nares 
swabs within 24 
hours of birth 
and/or on 
discharge from 
hospital (selective 
culture) 
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
141 women 
colonised with 
GBS on rectal 
swabs in labour 
(selective and 
standard culture) 
39 neonates 
colonised with 
GBS on rectum, 
umbilicus, ear and 
external nares 
swabs within 24 
hours of birth 
and/or on 
discharge from 
hospital (selective 
culture) 
Gerards 
1985
24
 
Netherlands 
Prospective 
cohort 
study  
Bacterial 
load - 
number of 
colony 
counts per 
plate 
Neonatal 
colonisation 
to EOGBS 
68 neonates 
colonised with 
GBS on nose, 
throat, external 
auditory meatus, 
eyes, umbilicus, 
skin and rectum 
swabs 
immediately 
21 neonates with 
EOGBS: Sepsis 
symptoms with 
GBS cultured 
from normally 
sterile culture <7 
days 
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
after admission 
to NICU 
(selective 
culture) 
Neonatal 
colonisation 
to probable 
GBS 
66 neonates 
colonised with 
GBS on nose, 
throat, external 
auditory meatus, 
eyes, umbilicus, 
skin and rectum 
swabs 
immediately 
after admission 
to NICU 
(selective 
culture) 
19 probable 
sepsis: Symptoms 
with nose, throat, 
external auditory 
meatus, eyes, 
umbilicus, skin 
and rectum swans 
but no culture 
from sterile site 
Jones  
1984
26
 
USA 
Prospective 
cohort 
study 
Bacterial 
load - 
Colony-
Maternal 
colonisation 
to neonatal 
130 women 
colonised with 
GBS on vaginal 
61 neonates 
colonised with 
GBS on rectum, 
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
forming 
units (cfu) 
per ml 
colonisation swabs at labour 
(selective 
culture) 
nasopharynx, and 
umbilicus swabs 
at birth (selective 
culture)  
Maternal 
colonisation 
to EOGBS 
2 neonates with 
EOGBS: blood 
culture positive  
1 neonate with 
probable EOGBS: 
symptoms and 
surface culture 
positive but not 
blood culture 
positive 
Persson 198629 
Sweden 
Secondary 
analysis 
combined 
with a 
prospective 
cohort 
Bacterial 
load - 
Colony-
forming 
units (cfu) 
per ml 
Maternal 
colonisation 
to neonatal 
colonisation 
64 women 
colonised with 
GBS on urine 
swab in labour 
(selective 
culture) 
12 neonates 
colonised with 
GBS on rectal 
swabs <5 days 
(selective culture) 
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
study  
Sensini  
199730 
Italy 
Prospective 
cohort 
study  
Bacterial 
load - 
Colony-
forming 
units (cfu) 
per ml 
Maternal 
colonisation 
to neonatal 
colonisation 
260 women 
colonised with 
GBS on lower 
vaginal swabs in 
labour (selective 
culture) 
108 neonates 
colonised with 
GBS on auricular, 
pharyngeal and 
gastric aspirate 
swabs before first 
bath (selective 
culture) 
Bacterial 
load - 
Colony-
forming 
units (cfu) 
per ml 
Maternal 
colonisation 
to EOGBS 
1 neonate with 
EOGBS sepsis: 
Blood culture and 
sepsis symptoms 
<24 hours AC
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
Boyer  
198320 
USA 
Prospective 
cohort 
study  
Bacterial 
load - 
other 
Maternal 
colonisation 
to neonatal 
colonisation 
207 women 
colonised with 
GBS on vaginal 
swabs in labour 
who gave birth to 
209 neonates 
(selective 
culture) 
89 neonates 
colonised with 
GBS on throat, 
umbilicus, rectum, 
external ear and 
nasogastric 
aspirate swabs in 
the delivery room  
Maternal 
colonisation 
to EOGBS 
4 neonates with 
EOGBS 
(definition not 
stated) 
Morales  
1986  
USA28 
Untreated 
control 
group of 
RCT 
 
Bacterial 
load - 
other 
Maternal 
colonisation 
to neonatal 
colonisation 
128 women 
colonised with 
GBS at labour 
identified by a 
rapid slide 
coagglutination 
test on selective 
vaginal culture 
59 term neonates 
colonised with 
GBS on 
oropharynx and 
the skin swabs at 
delivery and a 
urine latex-
agglutination  
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
 Maternal 
colonisation 
to EOGBS 
3 term neonates 
with GBS sepsis: 
Positive body 
fluid 
Morales 
198727 
USA 
Prospective 
cohort 
study 
Bacterial 
load - 
other 
Maternal 
colonisation 
to neonatal 
colonisation 
48 women 
colonised with 
GBS in labour 
identified by 
latex 
agglutination on 
selective vaginal 
culture 
17 pre-term 
neonates 
colonised with 
GBS detected by 
urine latex-
agglutination after 
delivery 
 Maternal 
colonisation 
to EOGBS 
13 pre-term 
neonates with 
GBS sepsis: 
Blood, CSF, or 
urine culture, and 
oropharynx 
cultures with 
radiographic and 
clinical signs of 
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Study ID 
Country 
Study 
design 
Risk 
factors 
GBS natural 
history 
pathway  
Participants 
and GBS 
culture method 
Outcome, 
definition and 
measurement 
infection  
CSF cerebrospinal fluid, EOGBS early-onset GBS disease, GBS group B Streptococcus 
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Table 2: Statistical findings of the association between bacterial load and neonatal GBS 
Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
Number of positive sites 
Hoogkamp 
1982
25
 
Netherlands 
Neonatal 
colonisation 
Maternal colonisation 
Light: 1 site 
Heavy ≥2 sites  
 
64% 
9% 
 
36% 
91% 
RR of heavy: 2.53  
(1.93-3.31) 
(calculated from 
%) 
None 
Dillon 
198722 
USA 
EOGBS Neonatal colonisation  
Light: 1-2 sites 
Heavy: 3-4 sites 
 
1041 
383 
 
4 
20 
RR of heavy: 12.97  
(4.46- 37.70) 
None 
Pass 197933 EOGBS Neonatal colonisation    RR of heavy: 15.31  None 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
USA Light: 1-2 sites 
Heavy: 3-4 sites 
198 
84 
1 
7 
(1.91- 122.60) 
Number of colony counts per plate 
Hoogkamp 
1982
25
  
Netherlands 
Neonatal 
colonisation 
Maternal colonisation 
Light: <10 colonies 
Moderate: 10-50 colonies 
Heavy: >50 colonies 
 
70% 
50% 
13% 
 
30% 
50% 
87% 
Not calculated for 
heavy versus 
light/moderate as 
no raw numbers 
None 
Gerards 
1985
24
 
Netherlands 
EOGBS – 
culture 
proven 
Neonatal colonisation  
Light: <3 sites positive that were <10 
or 10-50 colonies per plate 
 
38 
 
 
2 
 
Moderate and 
heavy versus light: 
p<0.0005 
None 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
Moderate: <3 sites positive that were 
>50 colonies per plate OR  
≥3 sites positive that were <10-50 
colonies per plate 
Heavy: ≥3 sites positive that were >50 
colonies per plate 
9 
 
 
 
0 
15 
 
 
 
4 
Probable 
sepsis (no 
confirmatory 
culture from 
Neonatal colonisation 
Light: as above 
Moderate: as above 
Heavy: as above 
 
38 
9 
0 
 
4 
11 
4 
RR of heavy versus 
light and moderate: 
3.13  
(2.06- 4.76) 
None 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
a sterile site) 
Colony-forming units (cfu) per ml 
Jones 
1984
26
 
USA 
Neonatal 
colonisation 
 
Continuous variable of maternal GBS 
colonisation from 10
2
 to 10
8 
colony 
counts 
See text See text Correlation 
between cfu/GBS 
ml in mothers’ 
vagina and 
neonates’ rectum: 
p<0.001 
None 
Persson 
198629 
Neonatal 
colonisation 
Maternal colonisation 
Light colonisation: <10
4
 cfu/ml in 
 
49 
 
6 
RR of heavy: 6.11  
(2.52-14.81) 
None 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
Sweden  urine  
Heavy colonisation: ≥104 cfu/ml in 
urine 
 
3 
 
6 
Sensini 
199730 
Italy 
Neonatal 
colonisation 
 
Maternal colonisation 
Light: 10
2
-10
5 
cfu/ml 
Heavy: 10
6 
or greater 
 
78 
74 
 
34 
74 
RR of heavy: 1.65  
(1.19- 2.28) 
None 
EOGBS Maternal colonisation 
Light: as above 
Heavy: as above 
 
111 
148 
 
1 
0 
Not applicable Not 
applicable 
Other 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
Boyer 
198320 
USA 
Neonatal 
colonisation 
 
Maternal colonisation 
Light: Negative intrapartum vaginal 
culture but positive postpartum 
rectal/vaginal culture 
Moderate: Positive intrapartum vaginal 
culture on selective broth enrichment 
only 
Heavy: Positive intrapartum vaginal 
culture on direct plate as well as 
enrichment 
 
47* 
 
 
35 
 
 
 
38 
 
10* 
 
 
10 
 
 
 
69 
RR of heavy versus 
light and moderate: 
3.29 
(2.17- 4.99) 
None 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
EOGBS Maternal colonisation 
Light: as above 
Moderate: as above 
Heavy: as above 
 
57* 
45 
103 
 
0 
0 
4 
Not applicable Not 
applicable 
Morales 
198628 
USA 
Neonatal 
colonisation 
Maternal colonisation 
Light colonisation: Agglutination with 
GBS antigens was negative at 5 hours 
but positive at 20 hours 
Heavy colonisation: Agglutination with 
GBS antigens was detectable within 5 
 
 
 
63 
 
 
 
 
 
35 
 
 
RR of heavy: 2.24  
(1.63- 3.09) 
None 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
hours  6 24 
GBS sepsis Maternal colonisation  
Light colonisation: as above 
Heavy colonisation: as above 
 
98 
27 
 
0 
3 
Not applicable Not 
applicable 
Morales 
198727 
USA 
Neonatal 
colonisation 
 
Maternal colonisation 
Light colonisation: Positive latex 
agglutination identification at 20 hours 
but not at 5 hours 
Heavy colonisation: Positive latex 
agglutination identification at 5 hours 
 
28 
 
 
3 
 
9 
 
 
8 
RR of heavy: 2.99  
(1.52-5.87) 
None 
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Study ID 
Country 
Outcome Bacterial load definition  Number/ 
% 
without 
outcome 
Number/ 
% with 
outcome 
Summary 
measure (95% CI) 
Covariates 
adjusted 
for 
GBS sepsis Maternal colonisation 
Light colonisation: as above 
Heavy colonisation: as above 
 
31 
4 
 
6  
7 
RR of heavy: 3.92  
(1.66-9.25) 
None 
Cfu colony forming units, CI confidence interval, GBS group B Streptococcus, EOGBS early-onset GBS, RR risk ratio  
 *Two extra births: 57 infants from 55 mothers  
Numbers in italics were calculated by authors 
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Figure 1 
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Figure 2 
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Figure 3 
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